Journal of Vascular Medicine & Surgery

Abstract

High-Power Short-Duration (HPSD)?Already the Current State of the Art for Ablation of Atrial Fibrillation?

Alexander Francke*

Pulmonary vein isolation has been widely accepted as the primary interventional therapy for Atrial Fibrillation (AF). While there are numerous modalities to achieve electric isolation of the pulmonary veins, Radiofrequency (RF) ablation is most frequently used throughout the world. While we look back on over two decades of RF therapy, there is an ongoing discussion concerning the optimal RF delivery and power, with growing interest in High-Power Short- Duration (HPSD) ablations to improve procedural outcomes and long-term efficiency.

Here, we discuss current developments in HPSD ablation for atrial fibrillation with respect to procedural efficacy, efficiency and safety, as well as their implication for our current standard of care.

Published Date: 2021-11-29; Received Date: 2021-11-02